Adlai Nortye Group Ltd. (ANL)
15.06
+1.32
(+9.61%)
USD |
NASDAQ |
Aug 26, 16:00
15.06
0.00 (0.00%)
After-Hours: 20:00
Adlai Nortye Group Enterprise Value : 779.12M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 779.12M |
| August 24, 2026 | 803.79M |
| August 21, 2026 | 776.77M |
| August 20, 2026 | 777.94M |
| August 19, 2026 | 813.77M |
| August 18, 2026 | 803.79M |
| August 17, 2026 | 755.63M |
| August 14, 2026 | 750.34M |
| August 13, 2026 | 727.43M |
| August 12, 2026 | 740.94M |
| August 11, 2026 | 740.35M |
| August 10, 2026 | 749.16M |
| August 07, 2026 | 752.10M |
| August 06, 2026 | 784.99M |
| August 05, 2026 | 739.77M |
| August 04, 2026 | 735.66M |
| August 03, 2026 | 735.07M |
| July 31, 2026 | 735.66M |
| July 30, 2026 | 735.66M |
| July 29, 2026 | 683.38M |
| July 28, 2026 | 717.45M |
| July 27, 2026 | 680.45M |
| July 24, 2026 | 706.29M |
| July 23, 2026 | 748.58M |
| July 22, 2026 | 750.93M |
| Date | Value |
|---|---|
| July 21, 2026 | 735.66M |
| July 20, 2026 | 675.75M |
| July 17, 2026 | 649.32M |
| July 16, 2026 | 638.74M |
| July 15, 2026 | 596.45M |
| July 14, 2026 | 512.46M |
| July 13, 2026 | 514.81M |
| July 10, 2026 | 551.82M |
| July 09, 2026 | 599.39M |
| July 08, 2026 | 570.02M |
| July 07, 2026 | 604.68M |
| July 06, 2026 | 613.49M |
| July 02, 2026 | 529.50M |
| July 01, 2026 | 594.69M |
| June 30, 2026 | 647.55M |
| June 29, 2026 | 363.89M |
| June 26, 2026 | 315.47M |
| June 25, 2026 | 320.97M |
| June 24, 2026 | 349.47M |
| June 23, 2026 | 336.08M |
| June 22, 2026 | 329.21M |
| June 18, 2026 | 318.91M |
| June 17, 2026 | 324.40M |
| June 16, 2026 | 317.19M |
| June 15, 2026 | 361.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zai Lab Ltd. | 2.474B |
| Kintor Pharmaceutical Ltd. | -- |
| Jacobio Pharmaceuticals Group Co., Ltd. | -- |
| Rallybio Corp. | -3.242M |
| Q32 Bio, Inc. | 286.41M |
Enterprise Value Related Metrics
| Earnings Yield | -3.60% |
| Normalized Earnings Yield | -3.606 |